US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
アメリカ
USOTC
Teamviewer SE (PK) (TMVWF) 銘柄情報

Teamviewer SE (PK) (TMVWF)

7.39

0.00

(0.00%)

終了 6月16日 5:00AM

Teamviewer SE (PK) (TMVWF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

7.39

( - )

買値

6.20

売値

7.40

出来高

-

0.00 日の範囲 0.00

5.17 52 週間の範囲 11.14

時価総額

前日終値

7.39

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 1,197,335

発行済株式数

163,466,162

配当利回り

PER

6.93

1 株当たり利益 (EPS)

0.78

歳入

751.19M

純利益

122.81M

TeamViewer SE, together with its subsidiaries, provides remote connectivity solutions worldwide. The company offers TeamViewer remote, a remote access, control, and management solution; TeamViewer Tensor, an enterprise connectivity solution for remote support, control and management of enterprise IT... TeamViewer SE, together with its subsidiaries, provides remote connectivity solutions worldwide. The company offers TeamViewer remote, a remote access, control, and management solution; TeamViewer Tensor, an enterprise connectivity solution for remote support, control and management of enterprise IT, smart devices, and industrial equipment; TeamViewer Frontline, a digital workflow, instruction, and assistance for smart frontline operations; and TeamViewer Dex, a real-time diagnostics and remediation, monitoring and analytics for insights and AI-driven automation. It also provides augmented reality and mixed reality-based solutions for manual processes in logistics, manufacturing, and aftersales operations. The company was founded in 2005 and is headquartered in Göppingen, Germany. 詳細を表示

セクター

Technology

業界

Software & It Services

ウェブサイト

www.teamviewer.com

本社

Göppingen, Germany

設立

2026

Teamviewer SE (PK) is listed in the Technology sector of the その他OTC with ticker TMVWF. The last closing price for Teamviewer (PK) was US$7.39. Over the last year, Teamviewer (PK) shares have traded in a share price range of US$ 5.17 to US$ 11.14.

Teamviewer (PK) currently has 163,466,162 shares in issue. The market capitalisation of Teamviewer (PK) is US$1.21 billion. Teamviewer (PK) has a price to earnings ratio (PE ratio) of 6.93.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0.63	9.31952662722	6.76	7.55	6.76	133	7.165	CS
12	1.74	30.796460177	5.65	7.55	5.65	1043	5.86360877	CS
26	0.375	5.34568781183	7.015	7.55	5.17	686	5.95926695	CS
52	-3.27	-30.6754221388	10.66	11.14	5.17	1465	7.91284479	CS
156	-7.72	-51.0919920582	15.11	18.29	5.17	1644	10.80492975	CS
260	-32.7032	-81.5679466842	40.0932	40.1735	5.17	2010	16.15526346	CS

TMVWF - Frequently Asked Questions (FAQ)

What is the current Teamviewer SE (PK) share price?

The current share price of Teamviewer SE (PK) is US$ 7.39

How many Teamviewer SE (PK) shares are in issue?

Teamviewer SE (PK) has 163,466,162 shares in issue

What is the market cap of Teamviewer SE (PK)?

The market capitalisation of Teamviewer SE (PK) is USD 1.21B

What is the 1 year trading range for Teamviewer SE (PK) share price?

Teamviewer SE (PK) has traded in the range of US$ 5.17 to US$ 11.14 during the past year

What is the PE ratio of Teamviewer SE (PK)?

The price to earnings ratio of Teamviewer SE (PK) is 6.93

What is the cash to sales ratio of Teamviewer SE (PK)?

The cash to sales ratio of Teamviewer SE (PK) is 1.18

What is the registered address of Teamviewer SE (PK)?

The registered address for Teamviewer SE (PK) is Bahnhofsplatz 2, Göppingen, Baden-Württemberg, 73033

What is the Teamviewer SE (PK) website address?

The website address for Teamviewer SE (PK) is www.teamviewer.com

Which industry sector does Teamviewer SE (PK) operate in?

Teamviewer SE (PK) operates in the Software & IT Services sector

Homework.Investwell

Homework.Investwell 6分前

2017 Northwest Biotherapeutics, Inc.
4800 Montgomery Lane, Suite 800

Suite 800 is empty....🤔

Mdk1

Why this paper is highly interesting for Lightwave Logic (GROK)
This is a top-scored paper that strongly validates Lightwave Logic’s Perkinamine™ chromophore series 3 as a leading electro-optic material for next-generation datacenter optics.

Key Reasons Why It Matters:

janice shell

janice shell 15分前

Now that's a real head-scratcher! But shorts have to be smart, so I'd say torso and head.

gitreal

gitreal 18分前

Anyone with half a Brian can see this company is being crazy shorted!

Which half? Torso and head?

HyGro

NWBO could file an FDA application anytime but they haven't and have shown no intent to do so. Instead they are just burning more shareholder cash and if approved, will lose money on every dose because NICE will hammer the reimbursement down below Advent's costs. NWBO will lose money and collaps

US Market News

US Market News 23分前

TotalEnergies SE: Disclosure of Transactions in Own SharesJune 16, 2026 2:00 AM
Business Wire Regulatory News In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share

HyGro

Sorry, not enough. NWBO won't make any profit selling in the UK. NICE hates personalized oncology treatments and won't pay enough for NWBO to make a profit.
That's what counts. And NWBO will go under or just become Advent Contract Manufacturer. They have no cash or credit to fund any sub

biotechinvestor1

biotechinvestor1 27分前

Don’t start spazzing again, Alteogen circus clown. The Sanofi news is old.
Once Merck settles/licenses from Halozyme, Sanofi and all others will follow.
Your Alteogen stole IP from Halozyme and will pay a price for it. You can count on it.
The companies who have signed with Alte

Steady_T

Steady_T 27分前

Your theory will be put to the test after UK approval. I give it 6 months as a guess.

HyGro

What's true is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How many years are you going to wait to find out???

HyGro

What's True is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How long are you going to wait to find out???

Mdk1

Google Scholar alert - new article: "A Comparison of Plasmonic Modulator Structures in the O- and C-Band for the 400G/Lane IM/DD Era"
>>> " In ALL cases, the same electro-optic organic material, Lightwave Logic’s PerkinamineTM
chromophore series 3, was used " !
https://ieeexplor

CelestialSage6

CelestialSage6 35分前

Stop talking nonsense. Sanofi is conducting clinical trials using Alteogen's technology; what are your thoughts on this? Did you sense a crisis for Halozyme?

biotechinvestor1

biotechinvestor1 38分前

I love it when Alteogen fanboys post on this board. Nearly every time they show up, Halozyme has a run up.

DR_rugby

DR_rugby 38分前

Prophecy is coming

https://www.cnbc.com/2026/06/16/boj-rate-hike-historic-inflation.html

Japanese rates are going higher

Yen is yet to be stabilize

The great unwinding is coming soon

GLTA

BigBadWolf

BigBadWolf 45分前

Authorized Shares 1,800,000,000 06/15/2026
Outstanding Shares 1,619,034,363 06/15/2026 >5m
Restricted 480,530,670 06/15/2026 >5m
Unrestricted 1,138,503,693 06/15/2026
Held at DTC 1,011,499,104 06/15/2026 >8m

Authorized Shares 1,800,000,000 06/05/2026

4retire

4retire 48分前

One has to question why a “cash rich” company would need to raise $20-25 billion by going to bond sales that will be in 7 tranches, ranging from 2 to 30 years. The statement is that it’s for general purposes and to redo some current debt financing.

Based on recent financials, NVDA’

tank777

tank777 49分前

FACT CHECK:

The key distinction is between “eligible” and “selected.”

To date, CMS has not publicly released a list of approved CBD brands for the Substance Access Beneficiary Engagement Incentive (BEI) program.

That means:

Mr. Tate

Mr. Tate 49分前

Your Mother should've named you loser0. Awww did someone take your lunch money in school loser0? IMO

jhdf51

jhdf51 49分前

Great.. thank you.

ducci1

ducci1 50分前

Pivot Calcs: SPX Pivot 7549---R1 7582---S1 7521---SPY Pivot 754---R1 757---S1 752----ES Pivot 7601---R1 7667---S1 7555----VIX Pivot 16.35---R1 16.70---S1 15.85---15 min Bull/Bear R/Line 18.34!----!!LOL!!

Mr. Tate

Mr. Tate 50分前

Are you for real loser0? You always hide behind a computer screen loser0? IMO

Wolf-man jack

Wolf-man jack 55分前

WQLF SAYS: .Charlottes Web products Have Not been PUBLICLY STATED as being OFFICIALLY APPROVED. In the case of CV SCIENCES, the CMS Pilot Program still has time to Announce CV SCIENCES or are they already enrolled? Cornbread was never announced, so one can not reliably state that it is A True FACT Y

knrorrel

knrorrel 1時間前

Wow, that would be fantastic. It would be a dream come true for me after the many losses (FORW, BLEG, PAVS) this year... I have to admit, the latest news was fantastic; the company shouldn't be trading at this level and could soon see a massive surge—similar to how QBTS went from $0.50 to $20 years

Teamviewer (PK)

8.5% PERM INT BEARING SHS

0.666% until 19mar40 0.6...

Global X Carbon Credits ...

Ci Canadian Income and G...

BDO Unibank (PK)

5.50% Insts 03/02/38

Diamond Offshore Drilling

Agf Us Smallmid Cap Fund...

7.375% 28oct2032

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。